Rasmus Sejersten Ripa

Summary

Affiliation: University of Copenhagen
Country: Denmark

Publications

  1. ncbi request reprint Granulocyte-colony stimulating factor therapy to induce neovascularization in ischemic heart disease
    Rasmus Sejersten Ripa
    Department of Cardiology, Rigshospitalet, Copenhagen, Denmark
    Dan Med J 59:B4411. 2012
  2. doi request reprint Plasma YKL-40 and recovery of left ventricular function after acute myocardial infarction
    Anne Hedegaard
    Department of Cardiology, The Heart Centre, Rigshospitalet, Copenhagen University Hospital and University of Copenhagen, Faculty of Health Sciences, Copenhagen, Denmark
    Scand J Clin Lab Invest 70:80-6. 2010
  3. doi request reprint YKL-40 a new biomarker in patients with acute coronary syndrome or stable coronary artery disease
    Yongzhong Wang
    Medical Department B, Cardiac Catheterization Laboratory, The Heart Centre, Rigshospitalet, University Hospital Copenhagen, Faculty of Health Sciences, University of Copenhagen, Denmark
    Scand Cardiovasc J 42:295-302. 2008
  4. doi request reprint Timing of granulocyte-colony stimulating factor treatment after acute myocardial infarction and recovery of left ventricular function: results from the STEMMI trial
    Mikkel Overgaard
    Department of Cardiology, The Heart Centre, Rigshospitalet, Copenhagen University Hospital, Denmark
    Int J Cardiol 140:351-5. 2010
  5. doi request reprint The influence of genotype on vascular endothelial growth factor and regulation of myocardial collateral blood flow in patients with acute and chronic coronary heart disease
    Rasmus Sejersten Ripa
    Department of Cardiology, The Heart Centre, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
    Scand J Clin Lab Invest 69:722-8. 2009
  6. ncbi request reprint Short- and long-term changes in myocardial function, morphology, edema, and infarct mass after ST-segment elevation myocardial infarction evaluated by serial magnetic resonance imaging
    Rasmus Sejersten Ripa
    Department of Cardiology, The Heart Centre, University Hospital Rigshospitalet, Copenhagen, Denmark
    Am Heart J 154:929-36. 2007
  7. ncbi request reprint Bone marrow derived mesenchymal cell mobilization by granulocyte-colony stimulating factor after acute myocardial infarction: results from the Stem Cells in Myocardial Infarction (STEMMI) trial
    Rasmus Sejersten Ripa
    Department of Cardiology, The Heart Centre, University Hospital Rigshospitalet, DK 2100 Copenhagen Ø, Denmark
    Circulation 116:I24-30. 2007
  8. doi request reprint Small animal positron emission tomography imaging and in vivo studies of atherosclerosis
    Anne Mette Fisker Hag
    Cluster for Molecular Imaging, Faculty of Health and Medical Sciences, Department of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
    Clin Physiol Funct Imaging 33:173-85. 2013
  9. ncbi request reprint Circulating angiogenic cytokines and stem cells in patients with severe chronic ischemic heart disease--indicators of myocardial ischemic burden?
    Rasmus Sejersten Ripa
    Cardiac Catheterization Laboratory, University Hospital Rigshospitalet, Copenhagen, Denmark
    Int J Cardiol 120:181-7. 2007
  10. doi request reprint Association between lectin complement pathway initiators, C-reactive protein and left ventricular remodeling in myocardial infarction-a magnetic resonance study
    Mikkel Malby Schoos
    Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Denmark
    Mol Immunol 54:408-14. 2013

Collaborators

Detail Information

Publications14

  1. ncbi request reprint Granulocyte-colony stimulating factor therapy to induce neovascularization in ischemic heart disease
    Rasmus Sejersten Ripa
    Department of Cardiology, Rigshospitalet, Copenhagen, Denmark
    Dan Med J 59:B4411. 2012
    ..Ultimately, this will require large randomized, double-blind and placebo-controlled trials with "hard" clinical endpoints like mortality and morbidity...
  2. doi request reprint Plasma YKL-40 and recovery of left ventricular function after acute myocardial infarction
    Anne Hedegaard
    Department of Cardiology, The Heart Centre, Rigshospitalet, Copenhagen University Hospital and University of Copenhagen, Faculty of Health Sciences, Copenhagen, Denmark
    Scand J Clin Lab Invest 70:80-6. 2010
    ....
  3. doi request reprint YKL-40 a new biomarker in patients with acute coronary syndrome or stable coronary artery disease
    Yongzhong Wang
    Medical Department B, Cardiac Catheterization Laboratory, The Heart Centre, Rigshospitalet, University Hospital Copenhagen, Faculty of Health Sciences, University of Copenhagen, Denmark
    Scand Cardiovasc J 42:295-302. 2008
    ..Aim was to quantitate plasma YKL-40 in patients with ST-elevation myocardial infarction (STEMI) or stable chronic coronary artery disease (CAD), and YKL-40 gene activation in human myocardium...
  4. doi request reprint Timing of granulocyte-colony stimulating factor treatment after acute myocardial infarction and recovery of left ventricular function: results from the STEMMI trial
    Mikkel Overgaard
    Department of Cardiology, The Heart Centre, Rigshospitalet, Copenhagen University Hospital, Denmark
    Int J Cardiol 140:351-5. 2010
    ..However, recent studies suggest that timing of G-CSF therapy is crucial...
  5. doi request reprint The influence of genotype on vascular endothelial growth factor and regulation of myocardial collateral blood flow in patients with acute and chronic coronary heart disease
    Rasmus Sejersten Ripa
    Department of Cardiology, The Heart Centre, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
    Scand J Clin Lab Invest 69:722-8. 2009
    ....
  6. ncbi request reprint Short- and long-term changes in myocardial function, morphology, edema, and infarct mass after ST-segment elevation myocardial infarction evaluated by serial magnetic resonance imaging
    Rasmus Sejersten Ripa
    Department of Cardiology, The Heart Centre, University Hospital Rigshospitalet, Copenhagen, Denmark
    Am Heart J 154:929-36. 2007
    ..The aim of this study was to evaluate effects of therapy for STEMI on left ventricular function and perfusion and to test the hypothesis that myocardial perfusion by MRI predicts recovery of left ventricular function...
  7. ncbi request reprint Bone marrow derived mesenchymal cell mobilization by granulocyte-colony stimulating factor after acute myocardial infarction: results from the Stem Cells in Myocardial Infarction (STEMMI) trial
    Rasmus Sejersten Ripa
    Department of Cardiology, The Heart Centre, University Hospital Rigshospitalet, DK 2100 Copenhagen Ø, Denmark
    Circulation 116:I24-30. 2007
    ..In contrast, intracoronary infusion of bone marrow cells appears to improve ejection fraction. We aimed to evaluate the G-CSF mobilization of subsets of stem cells...
  8. doi request reprint Small animal positron emission tomography imaging and in vivo studies of atherosclerosis
    Anne Mette Fisker Hag
    Cluster for Molecular Imaging, Faculty of Health and Medical Sciences, Department of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
    Clin Physiol Funct Imaging 33:173-85. 2013
    ..Here, we review the current knowledge obtained from in vivo positron emission tomography studies of atherosclerosis performed in small animals...
  9. ncbi request reprint Circulating angiogenic cytokines and stem cells in patients with severe chronic ischemic heart disease--indicators of myocardial ischemic burden?
    Rasmus Sejersten Ripa
    Cardiac Catheterization Laboratory, University Hospital Rigshospitalet, Copenhagen, Denmark
    Int J Cardiol 120:181-7. 2007
    ....
  10. doi request reprint Association between lectin complement pathway initiators, C-reactive protein and left ventricular remodeling in myocardial infarction-a magnetic resonance study
    Mikkel Malby Schoos
    Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Denmark
    Mol Immunol 54:408-14. 2013
    ..Also, C-reactive protein (CRP) and ficolin-2 interact in vitro, but the role of the ficolins in IRI is unknown...
  11. doi request reprint G-CSF therapy with mobilization of bone marrow stem cells for myocardial recovery after acute myocardial infarction--a relevant treatment?
    Rasmus Sejersten Ripa
    Department of Cardiology, The Heart Centre, Rigshospitalet, Copenhagen University Hospital, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark
    Exp Hematol 36:681-6. 2008
    ..Cell-based therapies to improve cardiac function remain promising and further experimental and clinical studies are warranted to determine the future role of G-CSF...
  12. pmc Non-invasive imaging for subclinical coronary atherosclerosis in patients with peripheral artery disease
    Rasmus Sejersten Ripa
    Department of Clinical Physiology, Nuclear Medicine and PET, KF 4012 Rigshospitalet University Hospital, Blegdamsvej 9, DK 2100, Copenhagen, Denmark
    Curr Atheroscler Rep 16:415. 2014
    ..These novel imaging methods may lead to early detection of high-risk vulnerable plaques, enabling clinicians to improve risk stratification of patients with peripheral artery disease, and thus paving the way for individualized therapy. ..
  13. ncbi request reprint Myocardial regeneration induced by granulocyte-colony-stimulating factor mobilization of stem cells in patients with acute or chronic ischaemic heart disease: a non-invasive alternative for clinical stem cell therapy?
    Jens Kastrup
    Department of Cardiology, The Heart Centre, University Hospital Rigshospitalet, Copenhagen, Denmark
    Eur Heart J 27:2748-54. 2006
    ....
  14. pmc (18)F-FDG PET imaging of murine atherosclerosis: association with gene expression of key molecular markers
    Anne Mette Fisker Hag
    Cluster for Molecular Imaging, Faculty of Health and Medical Sciences and Department of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
    PLoS ONE 7:e50908. 2012
    ..To study whether (18)F-FDG can be used for in vivo imaging of atherogenesis by examining the correlation between (18)F-FDG uptake and gene expression of key molecular markers of atherosclerosis in apoE(-/-) mice...